PMINYSE

Picard Medical Inc.

Healthcare·Cardiovascular·Commercial·Tucson, AZ, United States
Cardiovascular

Picard Medical Inc. (PMI): 2 pipeline candidates · ~2 mo cash runway. Updated within the last hour.

6.3/10

BioSniper Score

4-factor signal · derived from public data

Cash Runway0.6

2.3 months

Financial Health10.0

D/E -8.75 · 0% dilution

Pipeline Maturity10.0

Lead: Approved

Pipeline Breadth4.6

2 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for Picard Medical Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$15.5M

Cash

$121K

Quarterly Burn

$3.8M

Runway

2.3 mo

Revenue

$1.1M

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Aug 2026
Today~7 mo out
Catalyst within runway

Pipeline (2 candidates)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

39

Total value held

$454K

HolderSharesValue
eversource wealth advisors, llc997$88K
state street corp83,751$87K
geode capital management, llc59,578$62K
aqr capital management llc55,262$57K
vanguard portfolio management llc30,208$31K
northern trust corp17,927$19K
new york state common retirement fund17,892$19K
charles schwab investment management inc16,130$17K
blackrock, inc.13,489$14K
hudson bay capital management lp10,614$11K

Showing top 10 of 39 institutional holders of Picard Medical Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

·CEO: Mr. Patrick N. J. Schnegelsberg

Frequently asked questions

How many drug candidates are in Picard Medical Inc.'s pipeline?

Picard Medical Inc. (PMI) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Picard Medical Inc.'s lead drug candidate?

Picard Medical Inc.'s most advanced tracked candidate is emperor tah (Preclinical) for Biventricular heart failure.

What is Picard Medical Inc.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, Picard Medical Inc. has approximately 2.3 months of cash runway.

What is Picard Medical Inc.'s market capitalization?

Picard Medical Inc.'s market capitalization is approximately $15.5M.

Who is the CEO of Picard Medical Inc.?

Mr. Patrick N. J. Schnegelsberg is the chief executive officer of Picard Medical Inc. (PMI).

Get the full picture on Picard Medical Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.